lunes, 5 de mayo de 2025

Tiragolumab/Atezolizumab Shows No Significant Benefit in PD-L1–High NSCLC Christos Evangelou, MSc, PhD May 05, 2025

https://www.medscape.com/viewarticle/tiragolumab-atezolizumab-shows-no-significant-benefit-pd-l1-2025a1000asr

No hay comentarios:

Publicar un comentario